http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4029800-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_97a285d8ecd0184a7e5d89a1e4e07997 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 |
| filingDate | 1976-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1977-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3281ee6f46995eaea7e5e807f37ae72f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_127effef397d3549585e573f1eda3238 |
| publicationDate | 1977-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-4029800-A |
| titleOfInvention | Neuromuscular blocking agents and antagonists |
| abstract | It is disclosed that 2-(4'-pyridyl)-1,3-dioxolane methiodide and 2-(1'-methyl-4'-piperidyl)-1,3-dioxolane hydroiodide are neuromuscular blocking agents or neuromuscular blocking agent antagonists, depending upon the amount of the drug administered. n At doses of 10 - 6 to 10 - 4 gm./kg. of body weight, they antagonize or reverse the effects of neuromuscular blocking agents, such as d-tubocurarine and succinylcholine, produce post-drug repetitive activity (PDR), block post-tetanic potentiation (PTP), have no direct muscle effect and reverse the PTP suppression caused by d-tubocurarine and succinylcholine; and at doses of 10 - 3 to 10 - 2 gm./kg. of body weight they act as neuromuscular blocking agents. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003065015-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004037895-A1 |
| priorityDate | 1976-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 108.